- Home
- RADX vs BMGL Comparison
RADX vs BMGL Comparison
Compare RADX & BMGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- BMGL
- Stock Information
- Founded
- RADX 2021
- BMGL 2001
- Country
- RADX Australia
- BMGL Singapore
- Employees
- RADX N/A
- BMGL N/A
- Industry
- RADX
- BMGL
- Sector
- RADX
- BMGL
- Exchange
- RADX NYSE
- BMGL NYSE
- Market Cap
- RADX 32.5M
- BMGL 36.1M
- IPO Year
- RADX N/A
- BMGL 2025
- Fundamental
- Price
- RADX $5.35
- BMGL $2.02
- Analyst Decision
- RADX Strong Buy
- BMGL
- Analyst Count
- RADX 3
- BMGL 0
- Target Price
- RADX $15.00
- BMGL N/A
- AVG Volume (30 Days)
- RADX 17.5K
- BMGL 6.7M
- Earning Date
- RADX 02-26-2025
- BMGL 01-01-0001
- Dividend Yield
- RADX N/A
- BMGL N/A
- EPS Growth
- RADX N/A
- BMGL N/A
- EPS
- RADX N/A
- BMGL 0.02
- Revenue
- RADX $204,609.00
- BMGL $7,342,469.00
- Revenue This Year
- RADX N/A
- BMGL N/A
- Revenue Next Year
- RADX N/A
- BMGL N/A
- P/E Ratio
- RADX N/A
- BMGL $113.17
- Revenue Growth
- RADX N/A
- BMGL 2.28
- 52 Week Low
- RADX $3.50
- BMGL $0.91
- 52 Week High
- RADX $50.82
- BMGL $9.40
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- BMGL N/A
- Support Level
- RADX N/A
- BMGL N/A
- Resistance Level
- RADX N/A
- BMGL N/A
- Average True Range (ATR)
- RADX 0.00
- BMGL 0.00
- MACD
- RADX 0.00
- BMGL 0.00
- Stochastic Oscillator
- RADX 0.00
- BMGL 0.00
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About BMGL BASEL MEDICAL GROUP LTD
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.